Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Toubnax Injection

Prescription Icon
Prescription Required

Marketer

Toubib Pharma Private Limited

Salt Composition

Tranexamic Acid (100mg)

Overview Toubnax Injection

Hemostatin Injection is indicated for hemorrhage management. It aids in preventing or minimizing blood loss associated with procedures such as tooth extraction, menorrhagia, abnormal uterine bleeding, epistaxis, and surgeries involving the oral cavity, prostate, or bladder. Hemostatin Injection is classified as an antifibrinolytic agent; its mechanism of action involves inhibiting clot dissolution, thereby controlling bleeding. Administration should be strictly under the guidance of a healthcare provider. Prior allergy to this medication is a contraindication. Frequently reported adverse effects include injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Patients with a history of cardiac surgery or renal impairment should disclose this information to their physician. This injection is considered safe for use during pregnancy and lactation, as well as in individuals with liver disease.

Uses of Toubnax Injection

Managing Hemorrhage

Major Benefits of Toubnax Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Toubnax Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Toubnax Injection:

Administering this medication will be done by your doctor or nurse; self-medication is strictly prohibited.

How Toubnax Injection works:

Hemostatic agent Toubnax Injection inhibits fibrinolysis, thus stabilizing blood clots and managing excessive hemorrhage associated with menstruation or post-surgical procedures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Toubnax Injection and alcohol may result in significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Toubnax Injection use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Toubnax Injection while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Toubnax Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Administering Toubnax Injection requires careful consideration in individuals with impaired renal function. Dosage modifications for Toubnax Injection may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Toubnax Injection in patients with liver impairment is likely safe. Available evidence indicates dose modification may not be necessary, however, physician consultation is advised.

What if you forget to take Toubnax Injection :

Should you forget a scheduled Toubnax Injection, seek your physician's advice.

Facts to Know About Toubnax Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Toubnax Injection

Toubnax Injection must be administered intravenously, via slow injection only. Intramuscular administration is contraindicated to minimize adverse reactions.
All medications carry potential side effects, though these are less likely if used as prescribed. Benefits generally outweigh risks. However, Toubnax Injection may rarely cause serious, potentially dangerous side effects such as anaphylaxis (rash, breathing difficulty, facial/oral/eyelid swelling), blood clots, or eye problems. Always consult your doctor before use and adhere strictly to their instructions.
Toubnax Injection helps stop bleeding by promoting blood clotting. Rarely, it may increase the risk of deep vein thrombosis (DVT), a blood clot in the leg. Studies suggest other factors may contribute to this risk, which appears higher in women. Always consult your doctor before using Toubnax Injection and follow their instructions carefully.
Long-term treatment with Toubnax Injection may affect your color vision. Regular eye exams are therefore recommended, and any vision changes should be reported to your doctor immediately. They may then discontinue the medication and prescribe an alternative.
Toubnax Injection facilitates blood clotting and, although rare, may cause potentially fatal blood clots in the lungs (pulmonary embolism). While uncommon, pulmonary embolism risk increases with overdose, prolonged immobility, or pre-existing conditions. Other contributing risk factors may also exist.
Take Toubnax Injection with or without food, but always with water. Swallow the injection whole; do not crush or chew it.
Dosage and treatment length for this medication vary depending on the condition being treated. For heavy menstrual bleeding, a typical course lasts up to five days. For other conditions, the doctor will determine the appropriate duration, which may be shorter or longer.
Toubnax Injection does not impair fertility. Prescribed for heavy menstrual bleeding, it shows no evidence of disrupting ovulation. Consequently, it's not a contraceptive and won't affect your pregnancy chances.
Toubnax Injection can effectively stop nosebleeds by promoting blood clotting. For persistent nosebleeds, a week-long course of treatment may be necessary.
Toubnax Injection
54